Insulin resistance is one of the central drivers of polycystic ovary syndrome (PCOS), affecting an estimated 35% to 80% of women with the condition depending on body weight and how it’s measured. When your cells stop responding efficiently to insulin, your body pumps out more of it to compensate. That excess insulin doesn’t just affect blood sugar. It acts directly on the ovaries, pushing them to produce more male hormones (androgens) than they should, which triggers many of the symptoms women with PCOS know well.
How Insulin Drives PCOS Symptoms
Insulin doesn’t only manage blood sugar. It also functions as a hormonal signal inside the ovaries, where it amplifies the effect of other reproductive hormones on cells called theca cells. These are the cells responsible for producing androgens like testosterone. When insulin levels run high, theca cells get an outsized signal to keep making androgens, even when the rest of the hormonal system isn’t calling for them.
This excess androgen production is what connects insulin resistance to the hallmark symptoms of PCOS: irregular or absent periods, acne, thinning hair on the scalp, and excess hair growth on the face and body. It also disrupts ovulation by interfering with the normal development of egg follicles. The ovaries may develop multiple small, fluid-filled sacs (the “cysts” in the name) that never mature enough to release an egg. So while PCOS looks like a reproductive problem on the surface, the metabolic dysfunction underneath is often what keeps the cycle going.
It Affects Lean Women Too
A common misconception is that insulin resistance in PCOS only matters if you’re overweight. Research tells a different story. In a study of adolescent females with PCOS who had a normal BMI, those with the condition still had significantly higher fasting insulin and insulin resistance scores compared to peers of the same weight without PCOS. They also had a less favorable ratio of adiponectin to leptin, two hormones that regulate metabolism and inflammation.
Interestingly, the same study found that among participants with higher body weight, insulin and metabolic markers didn’t differ much between those with and without PCOS. This suggests that in lean women, the insulin resistance tied to PCOS is a distinct metabolic feature of the condition itself, not just a consequence of carrying extra weight. If you have PCOS and a normal BMI, that doesn’t mean your insulin is behaving normally.
Signs You Might Notice
Insulin resistance doesn’t always show up on a basic blood test, but your body often gives clues. One of the most recognizable is acanthosis nigricans: patches of darkened, velvety skin that typically appear on the back of the neck, in the armpits, or under the breasts. In a study of Hispanic adolescents, those with these skin changes were significantly more likely to have obesity (57% vs. 7%) and higher body fat percentage, both closely tied to insulin resistance and PCOS symptoms.
Other signs are subtler. Intense sugar cravings, energy crashes after meals, difficulty losing weight (especially around the midsection), and persistent hunger even shortly after eating can all point to your body overproducing insulin to keep blood sugar in check. Many women describe a pattern of feeling “wired but tired,” where energy is unpredictable throughout the day.
How Insulin Resistance Is Measured
There’s no single perfect test. The most common screening tool is the HOMA-IR score, which is calculated from your fasting insulin and fasting glucose levels. In research on women with PCOS, a HOMA-IR cutoff of 2.64 was found to be the most useful threshold for identifying metabolic syndrome. At that cutoff, about 35% of PCOS patients showed clear evidence of insulin resistance. Lower thresholds (around 1.82) capture milder insulin resistance that may still be clinically relevant.
The 2023 International Evidence-Based Guideline for PCOS recommends that all women and adolescents with the condition have their blood sugar status assessed at diagnosis, regardless of BMI. The preferred method is a 75-gram oral glucose tolerance test (OGTT), which measures how your body handles a standardized sugar load over two hours. This catches problems that a simple fasting glucose test would miss. If an OGTT isn’t available, fasting glucose or HbA1c (a three-month average of blood sugar) can be used, though both are significantly less accurate. Blood sugar screening should then be repeated every one to three years, depending on your individual risk factors.
The Type 2 Diabetes Risk
This is where the long-term stakes become clear. In a study following women with PCOS over time, the age-adjusted prevalence of type 2 diabetes reached 39.3% by the end of follow-up, compared to just 5.8% in the general female population of a similar age. That’s roughly a seven-fold difference. The progression from insulin resistance to prediabetes to full type 2 diabetes isn’t inevitable, but without intervention it follows a predictable path: the pancreas works harder and harder to produce enough insulin until it can no longer keep up.
The 2023 guidelines also recommend annual blood pressure checks for all women with PCOS and a lipid panel (cholesterol, triglycerides) at diagnosis, with follow-up frequency based on results and overall cardiovascular risk. These aren’t just box-checking exercises. Women with PCOS face elevated cardiovascular risk that starts younger than most people expect.
Treatment and Management
The most widely prescribed medication for insulin resistance in PCOS is metformin, which helps cells respond to insulin more effectively and lowers the amount of glucose the liver releases into the bloodstream. The international PCOS guideline suggests a maximum daily dose of 2.5 grams for adults, though the optimal dose is still debated and clinical trials are actively comparing different dosing strategies. Metformin is typically started at a low dose and gradually increased to reduce digestive side effects, which are the most common reason women stop taking it.
Beyond medication, lifestyle changes have a direct, measurable impact on insulin sensitivity. Regular physical activity (both aerobic and resistance training) helps muscle cells absorb glucose more efficiently without needing as much insulin. Dietary approaches that reduce blood sugar spikes, such as pairing carbohydrates with protein or fat and choosing less processed sources of starch, address the same underlying problem from a different angle. Even modest weight loss of 5% to 10% of body weight, in women who are overweight, can meaningfully improve both insulin resistance and ovulatory function.
Inositol Supplements
One of the most studied supplements for insulin resistance in PCOS is inositol, a naturally occurring compound involved in insulin signaling inside cells. Two forms matter: myo-inositol and D-chiro-inositol. Research supports taking them together in a 40:1 ratio, which mirrors the natural ratio found in the blood of healthy women. In a clinical study, obese women with PCOS who took the combined 40:1 formulation for six months showed improved insulin sensitivity and better ovulatory function. Inositol products are widely available over the counter, but the ratio matters. Formulations with too much D-chiro-inositol relative to myo-inositol can actually worsen ovarian function.
Why Addressing Insulin Matters Most
Many PCOS treatments focus on individual symptoms: hormonal birth control for irregular periods, spironolactone for acne and hair growth, fertility medications for ovulation. These all have their place. But if insulin resistance is the engine driving your PCOS, treating symptoms without addressing the metabolic root means the underlying process continues. High insulin keeps stimulating androgen production, keeps disrupting ovulation, and keeps pushing you closer to type 2 diabetes and cardiovascular disease.
Targeting insulin resistance directly, whether through metformin, inositol, exercise, or dietary changes, can improve multiple PCOS symptoms simultaneously because it addresses the shared cause rather than each downstream effect one at a time. For many women, this shift in approach is what finally makes their treatment plan feel like it’s working.